mouse hepatocytes |
Function assay |
1 mM |
|
DMSO |
inhibits fatty acid synthesis with IC50 of 3.6 μM |
16753576 |
rat hepatocytes |
Function assay |
1 mM |
|
DMSO |
inhibits fatty acid synthesis with IC50 of 3.6 μM |
16753576 |
HEK293 |
Kinase assay |
200 μM |
|
DMSO |
activates endogenous AMPK |
17728241 |
CCL13 |
Kinase assay |
200 μM |
|
DMSO |
activates endogenous AMPK |
17728241 |
MEFs |
Function assay |
300 μM |
|
DMSO |
inhibits proteasomal function by an AMPK-independent mechanism |
18593584 |
epididymal clear cells |
Function assay |
200 μM |
|
DMSO |
inhibits the pH-mediated V-ATPase accumulation at the apical membrane |
19211918 |
3T3-L1 |
Function assay |
1.2 mM |
|
DMSO |
inhibits 3T3-L1 Adipogenesis |
19483304 |
3T3-L1 |
Function assay |
1.2 mM |
|
DMSO |
inhibits the Expression of AdipogenesisRelated Transcription Factors and Markers |
19483304 |
3T3-L1 |
Function assay |
1.2 mM |
|
DMSO |
inhibits Mitotic Clonal Expansion |
19483304 |
3T3-L1 |
cytotoxicity assay |
1.2 mM |
|
DMSO |
decreases Cell Viability |
19483304 |
3T3-L1 |
Kinase assay |
1.2 mM |
|
DMSO |
activates AMPK |
19483304 |
L6 skeletal muscle cells |
Function assay |
250 μM |
|
DMSO |
activates AMPK signaling pathways |
19828836 |
L6 skeletal muscle cells |
Function assay |
250 μM |
|
DMSO |
inhibits the Na+-K+-ATPase transport activity and cell surface abundance |
19828836 |
MDA-MB231 |
Apoptosis assay |
400 μM |
|
DMSO |
sensitizes human breast cancer cell lines to TRAIL-induced apoptosis |
19896469 |
BT474 |
Apoptosis assay |
400 μM |
|
DMSO |
sensitizes human breast cancer cell lines to TRAIL-induced apoptosis |
19896469 |
MCF7 |
Apoptosis assay |
400 μM |
|
DMSO |
sensitizes human breast cancer cell lines to TRAIL-induced apoptosis |
19896469 |
Mesenchymal stem cells |
Kinase assay |
10 µM |
|
DMSO |
induces a robust and sustained AMPK activation |
24104879 |
Mesenchymal stem cells |
cytotoxicity assay |
100 µM |
|
DMSO |
decreases the MSC proliferation |
24104879 |
MG-63 |
cytotoxicity assay |
10 µM |
|
DMSO |
inhibits H2O2-Induced Osteoblast Cell Death |
24960362 |
MC3T3-E1 |
cytotoxicity assay |
10 µM |
|
DMSO |
inhibits H2O2-Induced Osteoblast Cell Death |
24960362 |
MG-63 |
Apoptosis assay |
10 µM |
|
DMSO |
suppresses H2O2-Induced Osteoblast Cell Apoptosis |
24960362 |
MC3T3-E1 |
Apoptosis assay |
10 µM |
|
DMSO |
suppresses H2O2-Induced Osteoblast Cell Apoptosis |
24960362 |
MG-63 |
Function assay |
10 µM |
|
DMSO |
alleviates ROS accumulation and ATP depletion caused by H2O2 |
24960362 |
MC3T3-E1 |
Function assay |
10 µM |
|
DMSO |
alleviates ROS accumulation and ATP depletion caused by H2O2 |
24960362 |
MG-63 |
Function assay |
10 µM |
|
DMSO |
facilitates H2O2-induced autophagy activation |
24960362 |
MC3T3-E1 |
Function assay |
10 µM |
|
DMSO |
facilitates H2O2-induced autophagy activation |
24960362 |
PC3 |
Kinase assay |
100 µM |
|
DMSO |
upregulates the levels of AMPK and ACC phosphorylation |
25594043 |
PC3M |
Kinase assay |
100 µM |
|
DMSO |
upregulates the levels of AMPK and ACC phosphorylation |
25594043 |
PC3 |
Function assay |
100 µM |
|
DMSO |
induces PI3K/mTOR pathways |
25594043 |
PC3M |
Function assay |
100 µM |
|
DMSO |
induces PI3K/mTOR pathways |
25594043 |
PC3 |
Growth inhibitory assay |
100 µM |
|
DMSO |
suppresses proliferation |
25594043 |
PC3M |
Growth inhibitory assay |
100 µM |
|
DMSO |
suppresses proliferation |
25594043 |
MC3T3-E1 |
Kinase assay |
10 μM |
|
DMSO |
induces significant AMPK activation |
26891866 |
MC3T3-E1 |
Growth inhibitory assay |
10 μM |
|
DMSO |
inhibits Dex-induced osteoblast cell death |
26891866 |
MC3T3-E1 |
Function assay |
10 μM |
|
DMSO |
inhibits Dex-induced oxidative stress |
26891866 |
BL21 |
Function assay |
|
1 to 10 mins |
|
Binding affinity to human recombinant N-terminal AVI-tagged phosphorylated AMPK alpha1beta1gamma1 expressed in Escherichia coli BL21 cells after 1 to 10 mins by biolayer interferometry, Kd = 0.51 μM. |
26510622 |
BL21 |
Function assay |
|
1 to 10 mins |
|
Binding affinity to human recombinant N-terminal AVI-tagged phosphorylated AMPK alpha1beta2gamma1 expressed in Escherichia coli BL21 cells after 1 to 10 mins by biolayer interferometry, Kd = 14.5 μM. |
26510622 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Effect on AMPK activation in HeLa cells at 100 uM after 1 hr by immunoprecipitate kinase assay |
17855357 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Effect on AMPK phosphorylation in HeLa cells at 100 uM after 1 hr by immunoprecipitate kinase assay |
17855357 |
HeLa |
Function assay |
100 uM |
5 mins |
|
Effect on AMPK phosphorylation in HeLa cells at 100 uM after 5 mins by immunoprecipitate kinase assay |
17855357 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Effect on acetyl-CoA carboxylase phosphorylation in HeLa cells at 100 uM after 1 hr by densitometry |
17855357 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Reduction of AMPK phosphorylation in HeLa cells at 100 uM after 1 hr in presence of STO-609 by immunoprecipitate kinase assay |
17855357 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Reduction of AMPK activation in HeLa cells at 100 uM after 1 hr in presence of STO-609 by immunoprecipitate kinase assay |
17855357 |
HeLa |
Function assay |
100 uM |
1 hr |
|
Reduction of acetyl-CoA carboxylase phosphorylation in HeLa cells at 100 uM after 1 hr in presence of STO-609 by densitometry |
17855357 |
CMK |
Growth Inhibition Assay |
|
|
|
Inhibition of human CMK cell growth in a cell viability assay, IC50 = 0.002202 μM. |
SANGER |
SIG-M5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50 = 0.007856 μM. |
SANGER |
MV-4-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.02274 μM. |
SANGER |
GDM-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GDM-1 cell growth in a cell viability assay, IC50 = 0.02553 μM. |
SANGER |
A431 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50 = 0.02919 μM. |
SANGER |
NALM-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NALM-6 cell growth in a cell viability assay, IC50 = 0.03166 μM. |
SANGER |
KM12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 0.03213 μM. |
SANGER |
QIMR-WIL |
Growth Inhibition Assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 0.03642 μM. |
SANGER |
NH-12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 0.03689 μM. |
SANGER |
KASUMI-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KASUMI-1 cell growth in a cell viability assay, IC50 = 0.0418 μM. |
SANGER |
ML-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 0.04344 μM. |
SANGER |
YT |
Growth Inhibition Assay |
|
|
|
Inhibition of human YT cell growth in a cell viability assay, IC50 = 0.0467 μM. |
SANGER |
Daudi |
Growth Inhibition Assay |
|
|
|
Inhibition of human Daudi cell growth in a cell viability assay, IC50 = 0.04979 μM. |
SANGER |
OCI-AML2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 0.0572 μM. |
SANGER |
ALL-PO |
Growth Inhibition Assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 0.05793 μM. |
SANGER |
MOLT-16 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 0.06191 μM. |
SANGER |
EHEB |
Growth Inhibition Assay |
|
|
|
Inhibition of human EHEB cell growth in a cell viability assay, IC50 = 0.06325 μM. |
SANGER |
AM-38 |
Growth Inhibition Assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50 = 0.0644 μM. |
SANGER |
C8166 |
Growth Inhibition Assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50 = 0.06619 μM. |
SANGER |
RPMI-6666 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-6666 cell growth in a cell viability assay, IC50 = 0.06798 μM. |
SANGER |
BC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BC-1 cell growth in a cell viability assay, IC50 = 0.06973 μM. |
SANGER |
CTV-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 0.07303 μM. |
SANGER |
HC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HC-1 cell growth in a cell viability assay, IC50 = 0.08314 μM. |
SANGER |
JiyoyeP-2003 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay, IC50 = 0.08371 μM. |
SANGER |
RS4-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 0.08572 μM. |
SANGER |
PF-382 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PF-382 cell growth in a cell viability assay, IC50 = 0.0859 μM. |
SANGER |
G-361 |
Growth Inhibition Assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50 = 0.08815 μM. |
SANGER |
LOXIMVI |
Growth Inhibition Assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 0.08833 μM. |
SANGER |
A3-KAW |
Growth Inhibition Assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 0.09169 μM. |
SANGER |
EoL-1-cell |
Growth Inhibition Assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 0.09558 μM. |
SANGER |
LOUCY |
Growth Inhibition Assay |
|
|
|
Inhibition of human LOUCY cell growth in a cell viability assay, IC50 = 0.09641 μM. |
SANGER |
HL-60 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 0.09739 μM. |
SANGER |
MC116 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 0.10014 μM. |
SANGER |
CESS |
Growth Inhibition Assay |
|
|
|
Inhibition of human CESS cell growth in a cell viability assay, IC50 = 0.1011 μM. |
SANGER |
REH |
Growth Inhibition Assay |
|
|
|
Inhibition of human REH cell growth in a cell viability assay, IC50 = 0.10382 μM. |
SANGER |
HCC2157 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC2157 cell growth in a cell viability assay, IC50 = 0.10455 μM. |
SANGER |
HEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50 = 0.10728 μM. |
SANGER |
BL-70 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BL-70 cell growth in a cell viability assay, IC50 = 0.10805 μM. |
SANGER |
NCI-H1770 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 0.10865 μM. |
SANGER |
SK-MM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MM-2 cell growth in a cell viability assay, IC50 = 0.10944 μM. |
SANGER |
MONO-MAC-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50 = 0.11372 μM. |
SANGER |
SR |
Growth Inhibition Assay |
|
|
|
Inhibition of human SR cell growth in a cell viability assay, IC50 = 0.11387 μM. |
SANGER |
MOLT-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 0.11446 μM. |
SANGER |
KE-37 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 0.12924 μM. |
SANGER |
ST486 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ST486 cell growth in a cell viability assay, IC50 = 0.13527 μM. |
SANGER |
HDLM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 0.13616 μM. |
SANGER |
ARH-77 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ARH-77 cell growth in a cell viability assay, IC50 = 0.1406 μM. |
SANGER |
EB2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EB2 cell growth in a cell viability assay, IC50 = 0.14234 μM. |
SANGER |
CCRF-CEM |
Growth Inhibition Assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 0.14576 μM. |
SANGER |
HD-MY-Z |
Growth Inhibition Assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 0.14791 μM. |
SANGER |
BT-474 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50 = 0.15074 μM. |
SANGER |
KARPAS-45 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 0.16984 μM. |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 0.1715 μM. |
SANGER |
MC-CAR |
Growth Inhibition Assay |
|
|
|
Inhibition of human MC-CAR cell growth in a cell viability assay, IC50 = 0.17153 μM. |
SANGER |
MRK-nu-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MRK-nu-1 cell growth in a cell viability assay, IC50 = 0.17751 μM. |
SANGER |
MHH-PREB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 0.18242 μM. |
SANGER |
SK-NEP-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 0.18514 μM. |
SANGER |
BL-41 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BL-41 cell growth in a cell viability assay, IC50 = 0.18943 μM. |
SANGER |
CAS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50 = 0.19307 μM. |
SANGER |
NCI-H1522 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1522 cell growth in a cell viability assay, IC50 = 0.19355 μM. |
SANGER |
CA46 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CA46 cell growth in a cell viability assay, IC50 = 0.19556 μM. |
SANGER |
L-363 |
Growth Inhibition Assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 0.21121 μM. |
SANGER |
NCI-H2087 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50 = 0.21446 μM. |
SANGER |
GR-ST |
Growth Inhibition Assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 0.21764 μM. |
SANGER |
OPM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OPM-2 cell growth in a cell viability assay, IC50 = 0.21791 μM. |
SANGER |
U-698-M |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-698-M cell growth in a cell viability assay, IC50 = 0.21915 μM. |
SANGER |
CAL-148 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-148 cell growth in a cell viability assay, IC50 = 0.22342 μM. |
SANGER |
L-428 |
Growth Inhibition Assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 0.22499 μM. |
SANGER |
DEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50 = 0.22825 μM. |
SANGER |
LU-134-A |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50 = 0.23116 μM. |
SANGER |
MLMA |
Growth Inhibition Assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 0.23399 μM. |
SANGER |
DOHH-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 0.24513 μM. |
SANGER |
RPMI-8226 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 0.24596 μM. |
SANGER |
NCI-H2196 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2196 cell growth in a cell viability assay, IC50 = 0.24776 μM. |
SANGER |
COR-L279 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L279 cell growth in a cell viability assay, IC50 = 0.25293 μM. |
SANGER |
CAPAN-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50 = 0.25589 μM. |
SANGER |
NOMO-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 0.26322 μM. |
SANGER |
SUP-T1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SUP-T1 cell growth in a cell viability assay, IC50 = 0.26516 μM. |
SANGER |
MEG-01 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 0.2687 μM. |
SANGER |
CHP-126 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CHP-126 cell growth in a cell viability assay, IC50 = 0.26909 μM. |
SANGER |
HCC1599 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1599 cell growth in a cell viability assay, IC50 = 0.27841 μM. |
SANGER |
EB-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EB-3 cell growth in a cell viability assay, IC50 = 0.29293 μM. |
SANGER |
WSU-NHL |
Growth Inhibition Assay |
|
|
|
Inhibition of human WSU-NHL cell growth in a cell viability assay, IC50 = 0.29672 μM. |
SANGER |
COLO-684 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50 = 0.3025 μM. |
SANGER |
LAMA-84 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 0.30816 μM. |
SANGER |
TGW |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGW cell growth in a cell viability assay, IC50 = 0.31095 μM. |
SANGER |
NCI-SNU-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 0.31106 μM. |
SANGER |
MHH-NB-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 0.32291 μM. |
SANGER |
COLO-824 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50 = 0.32838 μM. |
SANGER |
U-87-MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50 = 0.33314 μM. |
SANGER |
HT |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50 = 0.33482 μM. |
SANGER |
THP-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human THP-1 cell growth in a cell viability assay, IC50 = 0.34164 μM. |
SANGER |
HCC2218 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50 = 0.3418 μM. |
SANGER |
KARPAS-422 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KARPAS-422 cell growth in a cell viability assay, IC50 = 0.34433 μM. |
SANGER |
EM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 0.34443 μM. |
SANGER |
TUR |
Growth Inhibition Assay |
|
|
|
Inhibition of human TUR cell growth in a cell viability assay, IC50 = 0.34453 μM. |
SANGER |
MN-60 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 0.34596 μM. |
SANGER |
DMS-153 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DMS-153 cell growth in a cell viability assay, IC50 = 0.37276 μM. |
SANGER |
J-RT3-T3-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 0.37831 μM. |
SANGER |
EVSA-T |
Growth Inhibition Assay |
|
|
|
Inhibition of human EVSA-T cell growth in a cell viability assay, IC50 = 0.38095 μM. |
SANGER |
SHP-77 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50 = 0.38298 μM. |
SANGER |
D-283MED |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 0.38569 μM. |
SANGER |
GOTO |
Growth Inhibition Assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 0.39536 μM. |
SANGER |
KMOE-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50 = 0.39664 μM. |
SANGER |
U-266 |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 0.40452 μM. |
SANGER |
NCI-H226 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50 = 0.40703 μM. |
SANGER |
KG-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 0.40876 μM. |
SANGER |
NCI-H1882 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1882 cell growth in a cell viability assay, IC50 = 0.40912 μM. |
SANGER |
KMS-12-PE |
Growth Inhibition Assay |
|
|
|
Inhibition of human KMS-12-PE cell growth in a cell viability assay, IC50 = 0.41877 μM. |
SANGER |
KM-H2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 0.42374 μM. |
SANGER |
NCI-H1417 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1417 cell growth in a cell viability assay, IC50 = 0.43916 μM. |
SANGER |
RPMI-8402 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-8402 cell growth in a cell viability assay, IC50 = 0.44161 μM. |
SANGER |
EW-18 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50 = 0.45104 μM. |
SANGER |
HH |
Growth Inhibition Assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50 = 0.45751 μM. |
SANGER |
NCI-H526 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50 = 0.46847 μM. |
SANGER |
NEC8 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 0.48029 μM. |
SANGER |
P12-ICHIKAWA |
Growth Inhibition Assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50 = 0.48862 μM. |
SANGER |
DB |
Growth Inhibition Assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50 = 0.48893 μM. |
SANGER |
SJRH30 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50 = 0.49478 μM. |
SANGER |
ATN-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 0.49906 μM. |
SANGER |
ECC4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ECC4 cell growth in a cell viability assay, IC50 = 0.50901 μM. |
SANGER |
LU-65 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50 = 0.52007 μM. |
SANGER |
NCI-H1092 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50 = 0.54078 μM. |
SANGER |
NCI-H187 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H187 cell growth in a cell viability assay, IC50 = 0.54464 μM. |
SANGER |
LNCaP-Clone-FGC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50 = 0.5472 μM. |
SANGER |
LC4-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LC4-1 cell growth in a cell viability assay, IC50 = 0.56308 μM. |
SANGER |
NCI-H1436 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1436 cell growth in a cell viability assay, IC50 = 0.59043 μM. |
SANGER |
NCI-H2171 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2171 cell growth in a cell viability assay, IC50 = 0.62179 μM. |
SANGER |
LB647-SCLC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB647-SCLC cell growth in a cell viability assay, IC50 = 0.62241 μM. |
SANGER |
NCI-H2141 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2141 cell growth in a cell viability assay, IC50 = 0.63266 μM. |
SANGER |
NCI-H1304 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 0.63388 μM. |
SANGER |
Raji |
Growth Inhibition Assay |
|
|
|
Inhibition of human Raji cell growth in a cell viability assay, IC50 = 0.66976 μM. |
SANGER |
NB69 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50 = 0.68575 μM. |
SANGER |
NCI-H510A |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50 = 0.69172 μM. |
SANGER |
COR-L88 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 0.72456 μM. |
SANGER |
K052 |
Growth Inhibition Assay |
|
|
|
Inhibition of human K052 cell growth in a cell viability assay, IC50 = 0.79127 μM. |
SANGER |
SK-N-DZ |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 0.80231 μM. |
SANGER |
KY821 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 0.81743 μM. |
SANGER |
MDA-MB-157 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50 = 0.82406 μM. |
SANGER |
MS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 0.82745 μM. |
SANGER |
L-540 |
Growth Inhibition Assay |
|
|
|
Inhibition of human L-540 cell growth in a cell viability assay, IC50 = 0.84843 μM. |
SANGER |
MDA-MB-361 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50 = 0.86048 μM. |
SANGER |
NCI-SNU-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50 = 0.94375 μM. |
SANGER |
KARPAS-299 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 0.94828 μM. |
SANGER |
NCI-H1694 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1694 cell growth in a cell viability assay, IC50 = 0.9773 μM. |
SANGER |
P30-OHK |
Growth Inhibition Assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50 = 0.99292 μM. |
SANGER |
LU-165 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-165 cell growth in a cell viability assay, IC50 = 1.05606 μM. |
SANGER |
NB1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB1 cell growth in a cell viability assay, IC50 = 1.11241 μM. |
SANGER |
UACC-812 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UACC-812 cell growth in a cell viability assay, IC50 = 1.1488 μM. |
SANGER |
RL |
Growth Inhibition Assay |
|
|
|
Inhibition of human RL cell growth in a cell viability assay, IC50 = 1.16282 μM. |
SANGER |
NCI-H69 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50 = 1.19391 μM. |
SANGER |
SW1417 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50 = 1.23671 μM. |
SANGER |
NCI-H1155 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50 = 1.27588 μM. |
SANGER |
NCI-H1581 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 1.44028 μM. |
SANGER |
MHH-CALL-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-CALL-2 cell growth in a cell viability assay, IC50 = 1.48514 μM. |
SANGER |
SCLC-21H |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCLC-21H cell growth in a cell viability assay, IC50 = 1.67837 μM. |
SANGER |
LK-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50 = 1.71089 μM. |
SANGER |
CPC-N |
Growth Inhibition Assay |
|
|
|
Inhibition of human CPC-N cell growth in a cell viability assay, IC50 = 1.76764 μM. |
SANGER |
SCC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-3 cell growth in a cell viability assay, IC50 = 2.04311 μM. |
SANGER |
NCI-H446 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 2.05293 μM. |
SANGER |
RH-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50 = 2.13933 μM. |
SANGER |
NCI-H345 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H345 cell growth in a cell viability assay, IC50 = 2.14996 μM. |
SANGER |
A253 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A253 cell growth in a cell viability assay, IC50 = 2.25377 μM. |
SANGER |
DMS-79 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DMS-79 cell growth in a cell viability assay, IC50 = 2.36386 μM. |
SANGER |
SK-N-FI |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 2.50034 μM. |
SANGER |
SK-MEL-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50 = 2.61066 μM. |
SANGER |
HuO-3N1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50 = 2.69128 μM. |
SANGER |
SIMA |
Growth Inhibition Assay |
|
|
|
Inhibition of human SIMA cell growth in a cell viability assay, IC50 = 2.72143 μM. |
SANGER |
SU-DHL-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SU-DHL-1 cell growth in a cell viability assay, IC50 = 2.90246 μM. |
SANGER |
P31-FUJ |
Growth Inhibition Assay |
|
|
|
Inhibition of human P31-FUJ cell growth in a cell viability assay, IC50 = 3.01209 μM. |
SANGER |
A101D |
Growth Inhibition Assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50 = 3.23245 μM. |
SANGER |
RPMI-8866 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50 = 3.58797 μM. |
SANGER |
NCI-H209 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 3.59247 μM. |
SANGER |
JVM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 3.62244 μM. |
SANGER |
LP-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LP-1 cell growth in a cell viability assay, IC50 = 3.79042 μM. |
SANGER |
IST-SL1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 3.91611 μM. |
SANGER |
TE-9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 3.99619 μM. |
SANGER |
NCI-H1618 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1618 cell growth in a cell viability assay, IC50 = 4.17788 μM. |
SANGER |
COR-L105 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50 = 4.51462 μM. |
SANGER |
KU-19-19 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50 = 4.56729 μM. |
SANGER |
HCC70 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50 = 5.75167 μM. |
SANGER |
DG-75 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DG-75 cell growth in a cell viability assay, IC50 = 6.18885 μM. |
SANGER |
CCF-STTG1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CCF-STTG1 cell growth in a cell viability assay, IC50 = 6.74902 μM. |
SANGER |
SBC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50 = 6.88808 μM. |
SANGER |
CAL-85-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50 = 7.45587 μM. |
SANGER |
BxPC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50 = 7.56085 μM. |
SANGER |
YAPC |
Growth Inhibition Assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50 = 7.74286 μM. |
SANGER |
HCC1806 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50 = 8.04507 μM. |
SANGER |
SK-MEL-28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50 = 8.42441 μM. |
SANGER |
Ca9-22 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50 = 8.62748 μM. |
SANGER |
NCI-H889 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H889 cell growth in a cell viability assay, IC50 = 9.42457 μM. |
SANGER |
HT-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50 = 9.4754 μM. |
SANGER |
H4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50 = 9.59864 μM. |
SANGER |
NCI-H2228 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50 = 9.87581 μM. |
SANGER |
M14 |
Growth Inhibition Assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50 = 10.5224 μM. |
SANGER |
OVCAR-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50 = 11.4748 μM. |
SANGER |
HCC1187 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 11.4776 μM. |
SANGER |
RT4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RT4 cell growth in a cell viability assay, IC50 = 11.6532 μM. |
SANGER |
SW962 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 12.004 μM. |
SANGER |
BB49-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 12.0436 μM. |
SANGER |
HCE-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 12.7585 μM. |
SANGER |
KU812 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 13.9562 μM. |
SANGER |
JAR |
Growth Inhibition Assay |
|
|
|
Inhibition of human JAR cell growth in a cell viability assay, IC50 = 14.113 μM. |
SANGER |
NCI-H2009 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50 = 14.287 μM. |
SANGER |
HuO9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuO9 cell growth in a cell viability assay, IC50 = 14.4446 μM. |
SANGER |
U-118-MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50 = 14.5013 μM. |
SANGER |
SH-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 14.942 μM. |
SANGER |
ES5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 15.3528 μM. |
SANGER |
NB6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50 = 15.4452 μM. |
SANGER |
COLO-829 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50 = 15.6978 μM. |
SANGER |
NCI-H524 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H524 cell growth in a cell viability assay, IC50 = 15.751 μM. |
SANGER |
HPAF-II |
Growth Inhibition Assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50 = 16.1017 μM. |
SANGER |
GB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 16.5577 μM. |
SANGER |
LB771-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50 = 16.8228 μM. |
SANGER |
HuCCT1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50 = 17.176 μM. |
SANGER |
SW837 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50 = 17.3011 μM. |
SANGER |
NCI-N87 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50 = 17.5302 μM. |
SANGER |
BEN |
Growth Inhibition Assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50 = 17.7386 μM. |
SANGER |
Mewo |
Growth Inhibition Assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50 = 17.8382 μM. |
SANGER |
MPP-89 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 18.2784 μM. |
SANGER |
NOS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 18.3793 μM. |
SANGER |
Ca-Ski |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50 = 19.7889 μM. |
SANGER |
SW1088 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50 = 19.9447 μM. |
SANGER |
Capan-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50 = 20.3327 μM. |
SANGER |
A498 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50 = 20.4092 μM. |
SANGER |
COLO-800 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50 = 20.9232 μM. |
SANGER |
OVCAR-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 21.2508 μM. |
SANGER |
K-562 |
Growth Inhibition Assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 21.9049 μM. |
SANGER |
IA-LM |
Growth Inhibition Assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50 = 22.3771 μM. |
SANGER |
SK-LMS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 22.4057 μM. |
SANGER |
CAL-51 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50 = 23.0872 μM. |
SANGER |
NCI-H1651 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50 = 24.1303 μM. |
SANGER |
GMS-10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50 = 24.4376 μM. |
SANGER |
NCI-H2347 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50 = 24.6005 μM. |
SANGER |
MEL-JUSO |
Growth Inhibition Assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50 = 24.6906 μM. |
SANGER |
SW948 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50 = 24.9296 μM. |
SANGER |
MKN45 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50 = 26.4465 μM. |
SANGER |
HCC1954 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50 = 26.4502 μM. |
SANGER |
SAS |
Growth Inhibition Assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50 = 26.4732 μM. |
SANGER |
SCC-25 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50 = 26.5693 μM. |
SANGER |
MKN28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50 = 26.7093 μM. |
SANGER |
T84 |
Growth Inhibition Assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50 = 26.7743 μM. |
SANGER |
HCT-15 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50 = 26.9389 μM. |
SANGER |
DOK |
Growth Inhibition Assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50 = 27.0723 μM. |
SANGER |
SK-MEL-24 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50 = 28.0766 μM. |
SANGER |
HCC1143 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1143 cell growth in a cell viability assay, IC50 = 28.2552 μM. |
SANGER |
JEG-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50 = 28.4578 μM. |
SANGER |
SF539 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50 = 28.6049 μM. |
SANGER |
NB12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50 = 28.8033 μM. |
SANGER |
Hs-578-T |
Growth Inhibition Assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50 = 29.1197 μM. |
SANGER |
HCT-116 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50 = 29.4423 μM. |
SANGER |
EW-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 29.5269 μM. |
SANGER |
639-V |
Growth Inhibition Assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50 = 29.8546 μM. |
SANGER |
IGR-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50 = 30.0191 μM. |
SANGER |
LS-411N |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50 = 30.351 μM. |
SANGER |
D-502MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50 = 30.3725 μM. |
SANGER |
AN3-CA |
Growth Inhibition Assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50 = 31.4329 μM. |
SANGER |
RCC10RGB |
Growth Inhibition Assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50 = 31.4464 μM. |
SANGER |
GT3TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 31.7096 μM. |
SANGER |
BB30-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 32.5217 μM. |
SANGER |
HT-144 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 32.7065 μM. |
SANGER |
NCI-H1355 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 33.3495 μM. |
SANGER |
D-542MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50 = 33.3722 μM. |
SANGER |
NCI-H727 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50 = 33.4114 μM. |
SANGER |
NCI-H1755 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50 = 33.5236 μM. |
SANGER |
KS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 33.6298 μM. |
SANGER |
SW626 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50 = 33.7643 μM. |
SANGER |
MZ1-PC |
Growth Inhibition Assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 33.8103 μM. |
SANGER |
NCI-H1650 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 34.326 μM. |
SANGER |
LCLC-97TM1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50 = 34.8526 μM. |
SANGER |
HTC-C3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50 = 35.022 μM. |
SANGER |
SNU-387 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50 = 35.2684 μM. |
SANGER |
IM-9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IM-9 cell growth in a cell viability assay, IC50 = 35.5165 μM. |
SANGER |
KYSE-180 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50 = 35.6521 μM. |
SANGER |
HuH-7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50 = 35.6756 μM. |
SANGER |
CP66-MEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50 = 35.7968 μM. |
SANGER |
22RV1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50 = 35.8423 μM. |
SANGER |
SW48 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50 = 36.2464 μM. |
SANGER |
COLO-205 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-205 cell growth in a cell viability assay, IC50 = 37.2589 μM. |
SANGER |
MFH-ino |
Growth Inhibition Assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50 = 37.3918 μM. |
SANGER |
ECC12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ECC12 cell growth in a cell viability assay, IC50 = 37.7142 μM. |
SANGER |
CAL-72 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50 = 37.7221 μM. |
SANGER |
KNS-42 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50 = 37.8215 μM. |
SANGER |
U031 |
Growth Inhibition Assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50 = 37.827 μM. |
SANGER |
EFE-184 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EFE-184 cell growth in a cell viability assay, IC50 = 37.8863 μM. |
SANGER |
TCCSUP |
Growth Inhibition Assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50 = 38.3341 μM. |
SANGER |
TE-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 39.2614 μM. |
SANGER |
SK-MEL-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50 = 39.5577 μM. |
SANGER |
NCI-H1703 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50 = 39.5618 μM. |
SANGER |
NCI-H748 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H748 cell growth in a cell viability assay, IC50 = 39.6102 μM. |
SANGER |
HuP-T3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50 = 39.8492 μM. |
SANGER |
GCT |
Growth Inhibition Assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50 = 40.2935 μM. |
SANGER |
LU-99A |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50 = 40.6473 μM. |
SANGER |
TGBC24TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50 = 40.7998 μM. |
SANGER |
NCI-H1993 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50 = 41.1086 μM. |
SANGER |
769-P |
Growth Inhibition Assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50 = 41.226 μM. |
SANGER |
NCI-H2126 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50 = 41.3099 μM. |
SANGER |
NCI-H1563 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50 = 41.353 μM. |
SANGER |
NCI-H82 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 41.4039 μM. |
SANGER |
SW1783 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50 = 41.6769 μM. |
SANGER |
NCI-H1648 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 41.9392 μM. |
SANGER |
A388 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50 = 42.1236 μM. |
SANGER |
SK-MEL-30 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50 = 42.3151 μM. |
SANGER |
EKVX |
Growth Inhibition Assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50 = 42.3726 μM. |
SANGER |
A172 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50 = 42.8624 μM. |
SANGER |
OMC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50 = 42.9399 μM. |
SANGER |
PANC-03-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50 = 43.157 μM. |
SANGER |
NCI-H747 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 43.3223 μM. |
SANGER |
HT55 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50 = 43.7863 μM. |
SANGER |
BV-173 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 43.7946 μM. |
SANGER |
LS-1034 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50 = 43.9899 μM. |
SANGER |
NUGC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50 = 44.0773 μM. |
SANGER |
IST-MEL1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 44.2633 μM. |
SANGER |
8305C |
Growth Inhibition Assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50 = 44.31 μM. |
SANGER |
IMR-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IMR-5 cell growth in a cell viability assay, IC50 = 44.5743 μM. |
SANGER |
TE-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50 = 44.8539 μM. |
SANGER |
MZ2-MEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 45.0112 μM. |
SANGER |
RT-112 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50 = 45.4472 μM. |
SANGER |
SCC-9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50 = 45.5616 μM. |
SANGER |
SCC-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50 = 45.5626 μM. |
SANGER |
CAL-54 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50 = 45.6635 μM. |
SANGER |
LoVo |
Growth Inhibition Assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50 = 45.6839 μM. |
SANGER |
NCI-H358 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50 = 45.7286 μM. |
SANGER |
K5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50 = 46.029 μM. |
SANGER |
LB1047-RCC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 46.4256 μM. |
SANGER |
MES-SA |
Growth Inhibition Assay |
|
|
|
Inhibition of human MES-SA cell growth in a cell viability assay, IC50 = 46.5121 μM. |
SANGER |
UACC-257 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50 = 46.5175 μM. |
SANGER |
NCI-H2342 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50 = 46.8809 μM. |
SANGER |
TE-15 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-15 cell growth in a cell viability assay, IC50 = 46.8909 μM. |
SANGER |
SK-MES-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50 = 47.3821 μM. |
SANGER |
NCI-H322M |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H322M cell growth in a cell viability assay, IC50 = 47.6561 μM. |
SANGER |
SK-OV-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50 = 47.7452 μM. |
SANGER |
PANC-08-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50 = 47.9641 μM. |
SANGER |
786-0 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50 = 48.073 μM. |
SANGER |
NCI-H460 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50 = 48.1255 μM. |
SANGER |
D-336MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-336MG cell growth in a cell viability assay, IC50 = 48.4845 μM. |
SANGER |
SNG-M |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNG-M cell growth in a cell viability assay, IC50 = 48.6701 μM. |
SANGER |
SK-CO-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-CO-1 cell growth in a cell viability assay, IC50 = 49.0025 μM. |
SANGER |
CAL-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50 = 49.5334 μM. |
SANGER |
8505C |
Growth Inhibition Assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50 = 49.5364 μM. |
SANGER |
MCF7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50 = 49.5865 μM. |
SANGER |
T47D |
Growth Inhibition Assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50 = 49.7007 μM. |
SANGER |
YKG-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50 = 49.9412 μM. |
SANGER |